Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mental retardation, non-syndromic, autosomal recessive, 4 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||||
|
uncharacterized LOC101928437 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
fragile site, folic acid type, rare, fra(2)(q11.2) |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||||
|
chromosome 16 open reading frame 72-like |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
IQ motif and Sec7 domain ArfGEF 3 | 3.9E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||||
|
zinc finger protein 589 | 4.9E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
nuclear RNA export factor 4 pseudogene |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
protocadherin gamma subfamily A, 10 | 1.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
trafficking protein particle complex 6A | 0.931 | 5.1E-08 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MAP7 domain containing 3 | 4.6E-10 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||||
|
GTPase activating Rap/RanGAP domain like 3 | 6.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||||
|
general transcription factor IIIC subunit 3 | 1.000 | 7.0E-07 |
|
group | 0.300 | moderate | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
olfactory receptor family 5 subfamily M member 1 | 1.9E-03 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||||
|
UPF2 regulator of nonsense mediated mRNA decay | 1.000 | 0.038 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
zinc finger protein 544 | 1.000 | 0.038 | 1.0E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
family with sequence similarity 183 member A | 0.931 | 0.038 | 4.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
glycine receptor alpha 4 (pseudogene) | 1.000 | 0.038 | 9.4E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class B | 0.839 | 0.038 | 3.9E-11 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
potassium channel tetramerization domain containing 21 | 0.861 | 0.077 | 3.1E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
small vasohibin binding protein | 1.000 | 0.077 | 1.1E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
mental retardation, X-linked 82 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
centrosomal protein 83 | 0.839 | 0.077 | 4.3E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
WD repeat domain 83 opposite strand | 1.000 | 0.077 | 3.3E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
chromobox 3 pseudogene 2 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
interactor of little elongation complex ELL subunit 2 | 0.890 | 0.077 | 1.3E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 |